Introduction

Macroautophagy (hereafter autophagy) is a conserved lysosomal degradation process that maintains cellular homeostasis by removing damaged organelles and proteins [1, 2]. Its dysregulation is linked to cancer [3]. In tumors, autophagy suppresses initiation by clearing defective components and inducing cell death [4, 5], yet under stress (e.g., hypoxia, matrix detachment), it promotes tumor growth and metastasis [6,7,8,9].

Non-small cell lung cancer (NSCLC), representing approximately 85% of lung cancer cases, exhibits elevated basal autophagy that supports tumor growth and survival [10,11,12]. NSCLC is characterized by activation of nuclear Dbf2-related kinase 2 (NDR2) and the transcriptional coactivator YAP-1, both key components of the Hippo pathway [13, 14], which promotes tumor progression by enhancing cell migration and brain metastasis formation [14, 15].

The involvement of NDR2 in autophagy has been established in neurodegenerative diseases and osteoclastogenesis [16, 17], but remains poorly characterized in cancer. Notably, while NDR2 regulates autophagy in breast cancer [18, 19], its role in NSCLC remains unexplored. However, the Drosophila homolog of NDR1/2 interacts with autophagy-related protein 8 (ATG8), the mammalian LC3 equivalent [20]. Additionally, the mammalian autophagy protein ATG9A harbors a phosphorylation motif targeted by NDR2 [21, 22]. Since ATG9A is critical for early autophagosome biogenesis—delivering lipids and proteins to phagophore initiation sites via vesicular trafficking from the Golgi and endosomes [23,24,25,26,27,28,29,30]—it is plausible that NDR2 regulates ATG9A localization or activity.

Here, we demonstrate that NDR2, but not NDR1, is expressed in starved human bronchial epithelial tumor cells (HBECs) and promotes autophagy through regulation of LC3 and ATG9A. This NDR2-mediated autophagic activity enhances HBEC proliferation and migration, implicating NDR2 as a key modulator of autophagy in NSCLC progression.

Results

Serum deprivation for 24 h reduces NDR1 but not NDR2 in HBECs

HBEC cell lines (H2030, H2030-BrM3, and H1299) at 60–70% confluence (avoiding YAP-1 inhibition due to overconfluence) were cultured without fetal bovine serum (FBS) for 24 hours (deprivation) to induce autophagy [31]. Such starvation reduced cell density (Fig. S1A), but no apoptotic features were observed; rather the decrease was attributable to reduced cell proliferation, as indicated by Ki67 staining (Fig. S1A/B/C). HBECs are thus resistant to 24 h of FBS deprivation even if they proliferate less under these culture conditions.

To assess the effect of starvation on NDR1 and NDR2, we measured their mRNA and protein expression levels. Starvation did not alter NDR1 or NDR2 mRNA levels (Fig. 1A/B) but reduced NDR1 protein expression across all cell lines (Fig. 1C). Conversely, NDR2 protein levels increased depending on the cell line (Fig. 1D). Next, we depleted NDR2 expression in HBECs using siRNA or shRNA to determine whether NDR1 compensates for the loss of NDR2 function in HBECs cultured under FBS starvation conditions (Fig. 1B/D). Combined with serum deprivation, NDR2 depletion reduces NDR1 protein levels (Fig. 1C) but not its mRNA expression (Fig. 1A).

Fig. 1: NDR2 is expressed in HBECs grown in the absence of serum for 24 h, unlike NDR1.
figure 1

NDR2 was silenced (siNDR2 or shNDR2) in H2030, H2030-BrM3 and H1299 cells, which were then deprived of FBS for 24 h; control cells were transfected with siNeg or shCtr. A NDR1 mRNA expression. B NDR2 mRNA expression. C NDR1 protein blot and quantification. (D) NDR2 protein blot and quantification. The cells were arrested at 80% confluence. Two-way ANOVA followed by Tukey’s post hoc test were used to analyze the data, means ± SEMs, N = 3, *p < 0.05, **p < 0.01, ***p < 0.001 and ****p < 0.0001.

We then investigated whether NDR2 functions through the canonical Hippo pathway mechanism, that is, whether it is activated by MST kinases and regulates YAP-1 activity. During FBS starvation of H2030, NDR2 was not activated by the Hippo kinase MST, since FBS starvation silenced MST1 and MST3 but not MST2 (Fig. S2A). Starvation alone did not change YAP-1 nuclear localization but affected target gene expression variably (Fig. S3A/B/C). Silencing NDR2 reduced YAP-1 nuclear localization similarly to starvation (not significant in H2030 cells), and combining NDR2 depletion with starvation did not produce an additive effect (Fig. S3A), suggesting FBS deprivation activates NDR2 via a noncanonical Hippo pathway to regulate YAP-1.

NDR2 promotes autophagy induction by increasing LC3-II levels in HBECs

We tested whether NDR2 is involved in autophagy in HBECs. Treatment of H2030 cells with chloroquine (CQ, 10 µM) for 24 hours, an inhibitor of autophagosome-lysosome fusion [32], increased autophagosome numbers (Fig. 2A/B). After CQ treatment, cells were subjected to 24 h of FBS starvation, which further increased autophagosome numbers (Fig. 2B). However, NDR2 depletion tended to reduce autophagosome numbers in HBECs under both starvation and non-starvation conditions and significantly lowered them in CQ-treated HBECs (Fig. 2A/B). Notably, the autophagosome increase induced by combined CQ and starvation was absent in NDR2-depleted cells (Fig. 2A/B).

Fig. 2: NDR2 promoted autophagosome production in H2030 or H2030-BrM3 cells subjected to serum deprivation for 24 h.
figure 2

A H2030 cells were cultured in complete media (FBS) or starvation media (starvation) with or without DMSO or chloroquine (CQ) (10 µM) for 24 h and then treated with Cyto-ID. B Quantification of the intensity in (A). Blot showing LC3 and NDR2 levels in H2030 (C) and H2030-BrM3 (D) cells expressing or lacking NDR2 after 24 h of FBS deprivation. E Quantification of the blots in (C), including total LC3 expression, LC3-II expression and the LC3-II:LC3-I ratio, for H2030 cells. F Quantification of the blots in (D), including the expression of total LC3, expression of LC3-II and the LC3-II:LC3-I ratio, for H2030-BrM3 cells. G Blot showing kinetics of LC3 in H2030 and quantification of LC3 (H) and LC3-II (I) expression over 24 h of starvation, with or without NDR2 depletion. Quantification of SQSTM1/p62 protein levels in H2030 (J) and H2030-BrM3 cells (K). Two-way ANOVA followed Tukey’s post hoc test were used to analyze the data, means ± SEMs, N = 3, *p < 0.05, **p < 0.01, ***p < 0.001 and ****p < 0.0001.

Analysis of LC3, a key marker of autophagosome formation with LC3-II conversion indicating autophagy induction [33], showed decreased mRNA (Fig. S4A) and protein levels (Fig. 2C/D/E/F) upon NDR2 depletion, both under standard conditions and during starvation. The decrease in LC3 expression resulting from NDR2 silencing correlated with fewer LC3 puncta detected via immunofluorescence (Fig. S4B/C), indicating that the loss of NDR2 influenced the number of autophagosomes under serum deprivation conditions. In addition, NDR2 depletion decreased the protein expression of LC3 and LC3-II but only under starvation conditions (Fig. 2C/D/E/F). However, no difference was observed in LC3-II:LC3-I ratios (Fig. 2 E/F), suggesting that NDR2 was not involved in LC3 lipidation. During the 24 h starvation period, LC3 and LC3-II expression transiently decreased within the first 3 h, followed by an increase indicating autophagy activation (Fig. 2G/H/I). In NDR2-depleted cells, this increase occurred only after 6 h and remained lower than in controls (Fig. 2G/H/I). These findings suggest that NDR2 contributed to the regulation of autophagic mechanisms, by modulating LC3 expression during starvation (Figs. 2E/F/G/H/I and S4A/B/C).

NDR2 seemed more involved in serum deprivation-induced autophagy than in basal autophagy in HBECs, unlike NDR1, whose loss did not affect LC3 expression during serum starvation (Fig. S4D/E). The LC3 expression induced by NDR2 under starvation conditions may occur through the indirect activation of YAP1 by NDR2 (Fig. S3D/E).

SQSTM1/p62, a cargo degradation mediator whose levels decrease during autophagy [34, 35], showed increased mRNA expression following deprivation in HBECs (Fig. S4F). NDR2 depletion did not influence SQSTM1/p62 mRNA levels in H2030 cells, but decreased these levels in H2030-BrM3 cells (Fig. S4F). SQSTM1/p62 protein levels decreased in H2030 cells during deprivation, consistent with autophagosome degradation, but increased upon NDR2 silencing regardless of FBS presence (Fig. 2J). In H2030-BrM3 cells, SQSTM1/p62 levels were similar under serum and starvation conditions but NDR2 silencing decreased protein expression in both conditions (Fig. 2K), strengthening the hypothesis that NDR2 is involved in autophagy in HBECs.

To assess whether NDR2 influences autophagy through transcription factor EB (TFEB), a key regulator of autophagy-related genes, we measured the expression of selected TFEB target genes. In HBECs, we observed no variation in the expression of TFEB target genes (ATG3, ATG9, LAMP1, BECN1) attributable to NDR2 (Fig. S4G/H).

NDR2 prevents the accumulation of lysosomes and aggregates in HBECs

Following NDR2 silencing, an increase number of cells with large pericentriolar vacuolar structures was observed (Fig. 3A/B). With LysoTracker labeling, these structures were identified as primarily lysosomes (Fig. 3A). As observed with TEM, NDR2 depletion in HBECs induced the accumulation of much larger hyperdense structures than did NDR2 depletion in control (siNeg) cells (Fig. 3C), suggesting impaired cargo degradation and disrupted lysosomal trafficking or autophagosome fusion.

Fig. 3: NDR2 silencing induced the accumulation of lysosomes and aggregates in H2030 cells grown in the absence of serum for 24 h.
figure 3

A Phase contrast and fluorescence images of H2030 cells expressing or lacking NDR2 showing lysosome labeling with LysoTracker (green). B Quantification of vacuolated cells after transfection with siNDR2 and FBS deprivation for 24 h. C TEM images of H2030 cells transfected with either siNeg or siNDR2 showing the accumulation of hyperdense structures. D Immunostaining for NDR2 and SQSTM1/p62 in H2030 cells upon serum deprivation for 24 h. Two-way ANOVA followed by Tukey’s post hoc test were used to analyze the data, means ± SEMs, N = 3, **p < 0.05, **p < 0.01, ***p < 0.001 and ****p < 0.0001.

NDR2 kinase is essential for autophagy but does not directly interact with autophagosomes. Labeling of NDR2 and SQSTM1/p62 in H2030 cells revealed their proximity but no strict colocalization (Fig. 3D).

The shift in ATG9A subcellular localization in HBECs depends on NDR2

ATG9A is a transmembrane protein found in the trans-Golgi network (TGN), endosomes, and autophagosomes [23, 25] (Fig. 4A). Under serum starvation, ATG9A-positive vesicles fuse with phagophores, enabling their expansion into autophagosomes [23, 25]. NDR2 silencing changed the subcellular localization of ATG9A under normal conditions in HBECs (Figs. 4B/C and S5A/B). ATG9A translocated from the TGN to the cytoplasm in HBECs after FBS starvation (Fig. 4B/C), consistent with the increased number of autophagosomes observed under these conditions (Fig. 2). Serum-starvation-induced localization of ATG9A appears to require the presence of NDR2: in HBECs lacking NDR2, ATG9A is evenly distributed between the Golgi and the cytoplasm, whether cells are cultured in complete or serum-free medium (Figs. 4B/C and S5A/B). A colocalization of NDR2 with ATG9A was observed in H2030 cells with complete and starved medium, as in other HBECs (Fig. S5C/D), but not in cells transfected with siNDR2 or siATG9A as controls (Fig. 4D/E). Thus, NDR2 may contribute to ATG9A vesicle trafficking and phagophore biogenesis. This hypothesis was strengthened the presence of the NDR2 consensus phosphorylation motif (HxRxxS/T) [36] in the ATG9A sequence (Fig. 4A). Immunoprecipitation revealed an interaction between NDR2 and ATG9A consistent with substrate-enzyme relationship, suggesting that NDR2 may phosphorylate ATG9A to facilitate its trafficking (Fig. 4F).

Fig. 4: NDR2 governs the subcellular localization of ATG9A in H2030 cells.
figure 4

A Structural diagram of ATG9A. ATG9A possesses the consensus NDR2 phosphorylation motif (HXRXXT) in its cytoplasmic domain. Immunolabeling (B) and quantification of ATG9A localization (C) upon FBS deprivation for 24 h, with or without NDR2 silencing, in H2030 cells. D Colocalization of NDR2 and ATG9A immunolabeling in H2030 cells under normal or serum-deprived conditions and transfection of siNDR2 or siATG9A. E Quantification of NDR2-ATG9A colocalization. F Co-immunoprecipitation of ATG9A with NDR2 in H2030 cells, either non-transfected or transfected with a plasmid expressing a hyperactive NDR2 kinase (PIF), a kinase-dead variant (KD), or an empty pcDNA3 vector. NDR2 or/and ATG9A (siNDR2 or siATG9A) silenced or control (siNeg) H2030 cells were subjected to 24 h of serum deprivation or control culture. Immunolabeling (G) and quantification of SQSTM1/p62 puncta (H). I SQSTM1/p62 protein blot. J SQSTM1/p62 protein quantification. Two-way ANOVA followed by Tukey’s post hoc test were used to analyze the data, means ± SEMs, N = 3, *p < 0.05, **p < 0.01, ***p < 0.001 and ****p < 0.0001.

NDR2 and ATG9A co-depletion increased SQSTM1/p62 levels and puncta under both FBS and starvation, without additive effects, suggesting an involvement in common mechanism in autophagic processes (Fig. 4G/H/I/J).

This phenomenon may also occur in NSCLC tumors. We previously demonstrated that NDR2 is more highly expressed in metastatic NSCLC [14]. In the same patient cohort (25 cases of localized NSCLC and 20 cases of metastatic NSCLC), ATG9A expression also showed a tendency to be higher, although not significantly, in metastatic samples (Fig. 5). Consistent with our in vitro observations, the colocalization of NDR2 and ATG9A reveals a close spatial association between these proteins (Fig. 5A), suggesting a potential functional interaction that may promote autophagy in NSCLC.

Fig. 5: ATG9A is expressed in NSCLC and colocalizes with NDR2.
figure 5

A We immunostained a retrospective population of patients operated on a non-metastatic NSCLC (n = 25) or metastatic NSCLC (n = 20) for whom both the primitive tumor and the brain metastasis (BM) were available, with ATG9A (1:100) and we costained in fluorescence with NDR2 (1:200) and ATG9A (1:100). B Data are presented as the mean ± SEM of an IHC score, calculated by multiplying the staining intensity (0–3) by the distribution percentage (0–100%) and labeling localization.

NDR2 and ATG9A maintain the integrity of the Golgi apparatus

NDR2 depletion disrupted Golgi structure in H2030 cells (Fig. 6A). We categorized Golgi architecture into three distinct states: condensed, extended, or fragmented (Fig. 6B). The Golgi apparatus was condensed or extended in control condition (Fig. 6A/B). Under both serum deprivation and non-deprivation conditions, NDR2 silencing increased Golgi fragmentation (Fig. 6A/B). ATG9A depletion also caused Golgi fragmentation but to a lesser extent, with no additive effect seen during combined NDR2-ATG9A silencing. In contrast, FBS deprivation alone led to Golgi condensation (Fig. 6B). Golgi fragmentation was also observed with CQ treatment, suggesting that defects in autophagy may underlie fragmentation seen with NDR2 and/or ATG9A loss. (Fig. 6).

Fig. 6: NDR2 and ATG9A prevented the fragmentation of the Golgi apparatus in H2030 cells.
figure 6

A Immunolabeling of the Golgi with golgin-97 (green) in the H2030 cell line. B Diagram of the different classes of the Golgi identified in (A) (condensed, extended and fragmented) and quantification. A minimum of 150 cells were counted per experiment. Two-way ANOVA followed by Tukey’s post hoc test were used to analyze the data, means ± SEMs, N = 3, *p < 0.05, **p < 0.01 and ***p < 0.001.

NDR2-ATG9A control H2030 cells migration properties

A wound-healing assay was conducted after 24 h of serum deprivation or culture in complete medium, followed by cell migration under the same respective conditions. Six hours after wound healing, we quantified the number of HBECs exhibiting Golgi orientation toward the wound edge, indicative of directional migration [37]. Golgi orientation was defined as the apparatus positioned within a 90° angle from the nuclear center toward the wound [37, 38] (Fig. 7A). During starvation, the reorientation of the Golgi toward the migration front decreased in HBECs (Figs. 7B/C, S6A/B, S7A/B), which coincided with the decrease in the cell migration velocity (Fig. 8A and S8). NDR2 or ATG9A silencing decreased the number of cells with the Golgi apparatus positioned toward the migration front under all conditions (Fig. 7B/C), consistent with the decrease in migration speed observed in the presence or absence of serum for H2030 (Fig. 8A).

Fig. 7: NDR2 and ATG9A are required for the reorientation of the Golgi apparatus during migration.
figure 7

A Schematic representation of the disposition of the Golgi in migrating cells. B Illustration of the position of the Golgi (red) during migration (t6 h), (+) indicates cells with Golgi apparatus oriented toward the wound, (–) indicates cells with non-oriented Golgi. C Quantification of cells with the Golgi oriented toward the migration front during serum deprivation with or without the loss of NDR2 or ATG9A. Two-way ANOVA followed by Tukey’s post hoc test were used to analyze the data, means ± SEMs, N = 4, *p < 0.05, **p < 0.01, ***p < 0.001 and ****p < 0.0001.

Fig. 8: FBS deprivation and the loss of NDR2 or ATG9A decreased the migration capacity of H2030 cells.
figure 8

A Quantification of the wound-healing assay with H2030 cells with or without NDR2 and/or ATG9A silencing in full media or starvation media and with or without CQ. B Immunolabeling for phalloidin (green) and tubulin (red). C Quantification of the cell area using phalloidin labeling (B). D Immunolabeling of E-cadherin (green) and N-cadherin (red). E Quantification of the number of cells with N-cadherin membrane labelling and analysis via two-way ANOVA followed by Tukey’s post hoc test, means ± SEMs, N = 3, *p < 0.05, **p < 0.01, ***p < 0.001 and ****p < 0.0001.

Although MST3 was not expressed under starvation conditions (Fig. S2), its involvement in NDR2 activation and cell migration [39,40,41] led us to investigate this Golgi-associated kinase. Despite its stronger perinuclear/Golgi localization in metastatic versus localized NSCLC samples (Fig. S2B), MST3 did not affect Golgi structure or localization in H2030 cell (Fig. S2C/D). NDR2 effects on the Golgi was independent of its activation by MST3.

FBS deprivation before and after wounding reduced migration speed and shifted cells from collective to individual migration in HBECs (Figs. S6A/B, S7A/B, S8). Cells subjected to starvation followed by FBS replenishment (Starvation+FBS) migrated at similar speeds to those maintained in complete medium, except for H1299 cells, which migrated faster. However, this increase was absent upon inhibition of NDR2 (Fig. S7), which reduces filopodia formation by modifying the actin cytoskeleton without affecting vimentin or tubulin organization (Fig. S7D/E/F). No cytoskeletal changes were observed in other HBECs, while cell area decreased under serum deprivation (Figs. 8B/C and S6D).

NDR2 depletion reduced H2030 cell migration regardless of FBS availability (Fig. 8A). ATG9A silencing impaired migration only under FBS deprivation, while combined NDR2-ATG9A depletion decreased migration in all conditions (Figs. 8A and S8). Inhibition of autophagy by CQ reduced the migration rate of H2030 cells both in the presence and absence of FBS, indicating that autophagy contributed to the migratory capacity of these cells. NDR2 depletion alone results in a decrease comparable to that observed in siNeg cells treated with CQ. Moreover, CQ treatment of NDR2-depleted cells did not further enhance this effect. Similar results are observed following ATG9A depletion, either alone or in combination with NDR2 depletion (Fig. 8A). These findings suggested that NDR2 and ATG9A jointly promote cell migration under both nutrient-deprived and FBS-supplemented conditions, likely through the regulation of autophagy.

NDR2 and/or ATG9A loss also reduced membrane-associated N-cadherin, which accumulated perinuclear region (Fig. 8D/E).

Discussion

Consistent with the high basal autophagy in NSCLCs [42] and previous findings [43], we demonstrate here that HBECs tolerate 24 h of serum starvation. Moreover, we reveal that NDR1 is not involved in autophagy in HBECs and highlight a novel role for NDR2 kinase in bronchial carcinogenesis, specifically in autophagy initiation and autophagy-dependent migration. Indeed, while NDR1 regulates autophagosome formation in other models [42, 44,45,46,47], its expression is silenced in serum-starved HBECs, unlike NDR2. Moreover, NDR1 does not compensate for NDR2 silencing by siRNA or shRNA under these conditions. Thus, NDR2 appears to be the key NDR kinase controlling autophagy in HBECs. This supports previous reports [14, 22, 47, 48] indicating that NDR1 and NDR2 have non-redundant, and possibly opposing roles. Additional experiments are required to clarify: (i) the mechanism responsible for NDR1 degradation without affecting NDR2 in serum-starved HBECs, and (ii) how NDR2 activity is increased under these conditions. One possible explanation for NDR1 silencing is SOCS2, a starvation-induced E3 ligase that ubiquitinates NDR1 and triggers its degradation in mouse fibroblasts [48, 49]. Regarding NDR2 expression in serum-starved HBECs, our data indicate that its regulation is independent of Hippo MST kinases, as both MST1 and the NDR2-specific MST3 are then silenced. Instead, NDR2 may be activated via noncanonical pathways, such as MAP4K4, which promotes autophagy through SOX6 [50], or through SIRT1 [51], a key autophagy regulator [52].

Here, we show that once activated, NDR2 regulates autophagy through an indirect mechanism involving LC3 and ATG9A, further underscoring its oncogenic role. Similar to other NDR kinases (e.g., LATS1/2, NDR1), NDR2 regulates all proteins containing the HxRxxS/T motif [53], including YAP1 and TAZ, thereby influencing cell proliferation and survival [53], as well as additional substrates—not all yet identified—that support its diverse roles in both healthy and tumor cells [21, 54,55,56,57,58,59,60,61], particularly during hypoxia and metastatic dissemination in NSCLC. NDR2 is essential for autophagosome formation in HBECs, as its silencing reduces autophagosome numbers and promotes aggregate formation. NDR1/2 knockout lowers LC3 levels in neurons, but NDR2’s specific role in LC3 regulation remains unclear, unlike NDR1 [16]. In this study, we observed a decrease in LC3 expression in serum-starved HBECs following the depletion of NDR2, which could be one of the reasons for the observed reduction in autophagosome formation in HBECs. The regulation of LC3 by NDR2 does not depend on TFEB activity but could be mediated by YAP-1. Indeed, LC3 can also be transcribed by YAP-1 [62] and c-JUN [63], two transcription factors whose activity is promoted by NDR2 in hypoxic NSCLC cells [14]. YAP-1 activity decreased upon NDR2 loss in both serum-deprived and non-serum-deprived HBECs. The use of siYAP-1 resulted in a decrease in LC3 mRNA expression under deprivation conditions, with no additive effect observed when NDR2 and YAP-1 were simultaneously depleted, suggesting a novel regulatory axis of LC3 expression via NDR2-YAP-1. NDR2 also appears to transcriptionally regulate SQSTM1/p62 in a cell line-dependent manner, as its depletion reduces SQSTM1/p62 mRNA levels—but only in H2030-BrM3 cells. This finding supports the notion that NDR2 regulates a transcription factor involved in autophagy.

NDR2 regulates the subcellular localization of ATG9A, which plays a crucial role in early phagophore formation. Loss of NDR2 leads to ATG9A maldistribution and Golgi fragmentation. Golgi disruption impairs autophagy by affecting lipid and protein supply, as well as disrupting ATG9A vesicle trafficking [21, 64,65,66]. This observation aligns with Rosianu et al., who reported ATG9A peripheral localization and impaired autophagy in neurons following NDR1/2 knockout in mice [16]. Another mechanism may exist, as ATG9A contains an NDR2 phosphorylation motif. NDR2 could directly interact with ATG9A to promote its trafficking, potentially through the actin network [67], with which NDR2 also interacts, and via adaptor protein (AP) complexes, thereby enhancing autophagy [68]. Additional experiments are necessary to elucidate the precise mechanisms by which NDR2 may facilitate ATG9A vesicular trafficking and autophagosome biogenesis.

Autophagy influences cell migration in a context-dependent manner, either inhibiting it by regulating adhesions [69, 70] or promoting it via adhesion disassembly and EMT notably in NSCLC [71, 72]. Here, we showed that NDR2 and ATG9A are both involved in the localization of the Golgi apparatus in HBECs. NDR2 and/or ATG9A silencing disrupts the reorientation of the Golgi apparatus toward the leading edge of the cell in migration assays. Migrating cells establish polarity by reorienting the Golgi toward the leading edge, enabling targeted secretion that promotes cancer cell migration, invasion, and metastasis [37, 73]. Improper Golgi reorientation disrupts the accumulation of cytoskeletal elements at the wound site and impairs the recycling of key migration components [74, 75]. Under these conditions, the decrease in Golgi reorientation upon the depletion of NDR2 and/or ATG9A and the decrease in autophagy under these same conditions could impact the renewal and recycling of focal adhesion plaques and integrins and, consequently, cell migration. In glioblastoma, ATG9A promotes integrin trafficking to enable tumor cell migration [76]. Similarly, NDR2 may facilitate integrin trafficking via ATG9A in HBECs, consistent with its reported role in integrin transport during neuronal development [60, 61].

In conclusion, these data indicate that NDR2 has a novel role in autophagy in NSCLC cells under prolonged serum starvation by regulating LC3 and ATG9A. Additionally, the NDR2–ATG9A pathway enhances NSCLC cell migration during starvation. Further studies will be required to explore how the NDR2-ATG9A relationship interfaces with that of NDR2 and ULK1 [17, 18, 25, 27] during the autophagic process in healthy or tumor cells.

Materials and methods

Patients

We selected a retrospective cohort of 45 patients who underwent surgery for nonmetastatic NSCLC (n = 25) or metastatic NSCLC (n = 20) at Caen University Hospital between December 2009 and December 2019, with both primary tumor and brain metastasis samples available. Among the 25 localized NSCLC patients, 17 were men and 8 women, with a mean age of 71 years (range 54–86). Among the 20 metastatic NSCLC patients, 15 were men and 5 women, with a mean age of 67 years (range 40–82). All patients gave informed consent, and the study was approved by the institutional ethics committee, in accordance with French law (North-west-Committee-for-Persons-Protection-III No. DC-2008-588).

Cell culture transfection and treatments

The H1299 (CRL-5803) and H2030 (CRL-5914) lung adenocarcinoma cell lines were obtained from ATCC, while the brain-tropic H2030-BrM3 line was kindly provided by Dr. Joan Massagué (MSKCC, USA). All cells were cultured in high-glucose DMEM (4.5 g/L) supplemented with 10% heat-inactivated FBS, 100 U/mL penicillin, 100 μg/mL streptomycin, and 2 mM L-glutamine (Gibco). Stable shRNA-depleted lines for NDR1 and NDR2 (shNDR1, shNDR2), along with a control line (shCtr), were used for H1299 and H2030-BrM3, as described [15]. siRNA duplexes (Eurogentec®, Table S1) or plasmids (kindly provided by Dr. Alexander Hergovich, University College London) were transfected using JetPrime (Polyplus, 101000046) following the manufacturer’s protocol at 40% cell confluence. Transfection efficiency was routinely confirmed by RT‒PCR and/or Western blot.

For FBS starvation, cells were cultured for 24 h at 37 °C and 5% CO₂ in low-glucose DMEM (1000 mg/L) without FBS, supplemented with antibiotics and antimycotics.

For some experiments, chloroquine (CQ) was added at 10 µM to the culture medium for up to 24 hours.

The cells were regularly tested for mycoplasma contamination.

Preparation of RNA and RT-PCR

Total RNA was extracted using the ReliaPrep™ RNA Miniprep System (Promega) per the manufacturer’s protocol. Reverse transcription was performed on 250 ng RNA with random primers and 200 IU M-MLV reverse transcriptase at 37 °C for 90 min, followed by inactivation at 70 °C for 5 min (Mastercycler, Eppendorf®). cDNA was diluted 1:10 and used for qPCR on an Mx3005P system (Agilent Technologies) with 5 pmol primers and iQ™ SYBR Green Supermix (Bio-Rad). S16 was the internal control; positive and no-RT controls were included. Gene expression was quantified using the ΔΔCt method. The primers used are listed in Table S2.

Antibodies, immunofluorescence staining, immunoblotting, Immunoprecipitation

The antibodies used are listed in Table S3.

For immunofluorescence, 2 × 10⁴ cells were seeded on coverslips in 24-well plates, washed with PBS, fixed with 4% paraformaldehyde (20 min, 37 °C), and permeabilized with methanol (10 min, –20 °C). After blocking with 4% BSA in PBS for 1 hour, cells were incubated overnight at 4 °C with primary antibodies. Alexa-488 or Alexa-555 secondary antibodies (ThermoFisher Scientific) were applied for 1 h at room temperature. Nuclei were counterstained with DAPI (Fluoromount-GTM, Invitrogen). Imaging was performed on an Olympus FluoView FV1000 confocal microscope (60×, NA 1.20).

For immunoblotting, whole-cell extracts were prepared as described [14]. Proteins were separated by SDS-PAGE and detected with primary antibodies (1:1000) in TBS-T (0.1% Tween-20), HRP-conjugated secondary antibodies, and Clarity Western ECL (Bio-Rad). Signals were captured with an Odyssey Fc imager (Li-COR®) and quantified using ImageJ. GAPDH was used as a loading control.

Immunoprecipitation was carried out on extracts from T75-flask cultures using the Pierce Co-IP Kit (Thermo Scientific, 26149) following the manufacturer’s protocol.

Immunohistochemistry (IHC) was performed on 3 µm FFPE sections using the Discovery Ultra Ventana analyzer. After deparaffinization and antigen retrieval (Tris-EDTA buffer, pH 8.2), sections were incubated with anti-NDR2 (1:200), anti-ATG9 (1:100), and anti-MST3 (1:200). Denaturation was done with Ultra CC2 (Ventana, #950-223, 8 min, 100°C). For co-staining, HRP-conjugated secondary antibodies were detected using DISC. CY5 and FITC Kits (Ventana, #253-4928, #253-4881). Nuclei were counterstained with DAPI (Ventana, #760-4196).

Autophagy assay

The CYTO-ID® Autophagy Detection Kit (Enzo Life Sciences, ENZ-51031-0050) was used following the manufacturer’s instructions. Cells on glass coverslips were treated with 10 µM CQ for 24 hours prior to CYTO-ID staining. Images were acquired with an Olympus FluoView FV1000 confocal microscope and analyzed using ImageJ.

LysoTracker staining

LysoTracker™ Green DND-26 (50 nM; Cell Signaling Technology, 8783) was added to the culture medium. Live-cell imaging was performed immediately using a Leica DMi8 inverted microscope in a temperature- and CO₂-controlled chamber (37 °C, 5% CO₂). Images from three fields were captured with Metamorph 7.8.13.0 and analyzed using ImageJ.

Wound-healing assay

Transfected cells were seeded on collagen I-coated plates or collagen IV-coated plates, grown to confluence, and treated with mitomycin C (1 μg/mL) for 12 h to inhibit proliferation. Cells were then incubated in either full media or starvation media, with or without CQ at 10 µM. A scratch was made with a P-10 pipette tip (0 h), and migration was monitored for 20 h. Images were captured every 15 min using a ZEISS AXIO Observer 7 microscope equipped with a motorized stage, temperature-controlled chamber (37 °C, 5% CO₂, PECON) and a Hamamatsu ORCA FLASH 4 camera. Cell movements were tracked with a custom Python script using Cellpose and Trackpy libraries.

Statistical analysis

Data are shown as means ± SEM from three independent experiments. Statistical significance (p < 0.05) was assessed using two-tailed Student’s t-test or two-way ANOVA with Tukey’s post hoc test (the normality of the data distribution was assessed and the variance was similar between the groups that are being statistically compared) via GraphPad Prism 4 (San Diego, CA, USA).